NervGen Pharma Corp. (NGEN)
2.07
-0.01
(-0.48%)
USD |
NASDAQ |
May 29, 16:00
2.06
-0.01
(-0.48%)
After-Hours: 20:00
NervGen Pharma EPS Diluted (Quarterly) : -0.0153 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -0.7327 |
| Milestone Pharmaceuticals, Inc. | -0.2001 |
| Manzo Pharmaceuticals, Inc. | -- |
| Clearmind Medicine, Inc. | -33.17 |
| Pharmagreen Biotech, Inc. | -0.0017 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.222M |
| Total Expenses (Quarterly) | 1.222M |
| Enterprise Value | 207.97M |
| Earnings Yield | -19.28% |
| Normalized Earnings Yield | -14.40 |